Cargando…

Computational Analysis of Molnupiravir

In this work, we report in-depth computational studies of three plausible tautomeric forms, generated through the migration of two acidic protons of the N(4)-hydroxylcytosine fragment, of molnupiravir, which is emerging as an efficient drug to treat COVID-19. The DFT calculations were performed to v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharov, Artem V., Burkhanova, Tatyana M., Taskın Tok, Tugba, Babashkina, Maria G., Safin, Damir A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835990/ https://www.ncbi.nlm.nih.gov/pubmed/35163429 http://dx.doi.org/10.3390/ijms23031508

Ejemplares similares

Correction: Sharov et al. Computational Analysis of Molnupiravir. Int. J. Mol. Sci. 2022, 23, 1508
por: Sharov, Artem V., et al.
Publicado: (2022)

Naphthalene-based bis-N-salicylidene aniline dyes: Crystal structures, Hirshfeld surface analysis, computational study and molecular docking with the SARS-CoV-2 proteins
por: Burkhanova, Tatyana M., et al.
Publicado: (2021)

In silico analyses of betulin: DFT studies, corrosion inhibition properties, ADMET prediction, and molecular docking with a series of SARS-CoV-2 and monkeypox proteins
por: Burkhanova, Tatyana M., et al.
Publicado: (2022)

A Family of Ethyl N-Salicylideneglycinate Dyes Stabilized by Intramolecular Hydrogen Bonding: Photophysical Properties and Computational Study
por: Alkhimova, Larisa E., et al.
Publicado: (2021)

α-Aminophosphonates 4-XC(6)H(4)–NH–CH(4-BrC(6)H(4))–P(O)(OiPr)(2) (X = H, Br, MeO): Crystal structures, Hirshfeld surface analysis, computational studies and in silico molecular docking with the SARS-CoV-2 proteins
por: Alkhimova, Larisa E., et al.
Publicado: (2021)

Supramolecular structures of Ni(II) and Cu(II) with the sterically demanding Schiff base dyes driven by cooperative action of preagostic and other non-covalent interactions
por: Shiryaev, Alexey A., et al.
Publicado: (2021)

Favipiravir: insight into the crystal structure, Hirshfeld surface analysis and computational study
por: Babashkina, Maria G., et al.
Publicado: (2021)

Tetrel Bonding and Other Non-Covalent Interactions Assisted Supramolecular Aggregation in a New Pb(II) Complex of an Isonicotinohydrazide
por: Mahmoudi, Ghodrat, et al.
Publicado: (2020)

Molnupiravir: First Approval
por: Syed, Yahiya Y.
Publicado: (2022)

Molnupiravir for COVID-19
Publicado: (2022)

Publisher Correction: Molnupiravir: coding for catastrophe
por: Malone, Brandon, et al.
Publicado: (2021)

Molnupiravir, une affaire franco-européenne
por: Manus, Jean-Marie
Publicado: (2021)

Why Molnupiravir Fails in Hospitalized Patients
por: Brown, Ashley N., et al.
Publicado: (2022)

Molnupiravir; molecular and functional descriptors of mitochondrial safety
por: Wallace, K.B., et al.
Publicado: (2022)

Molnupiravir: From Hope to Epic Fail?
por: Focosi, Daniele
Publicado: (2022)

Solvent-Induced Formation of Novel Ni(II) Complexes Derived from Bis-Thiosemicarbazone Ligand: An Insight from Experimental and Theoretical Investigations
por: Mahmoudi, Ghodrat, et al.
Publicado: (2021)

Concise two-step chemical synthesis of molnupiravir
por: Pereira, Vinícius R. D., et al.
Publicado: (2022)

Correction: Structural versatility of the quasi-aromatic Möbius type zinc(ii)-pseudohalide complexes – experimental and theoretical investigations
por: Mitoraj, Mariusz P., et al.
Publicado: (2019)

Structural versatility of the quasi-aromatic Möbius type zinc(ii)-pseudohalide complexes – experimental and theoretical investigations
por: Mitoraj, Mariusz P., et al.
Publicado: (2019)

Correction: Mahmoudi et al. Solvent-Induced Formation of Novel Ni(II) Complexes Derived from Bis-Thiosemicarbazone Ligand: An Insight from Experimental and Theoretical Investigations. Int. J. Mol. Sci. 2021, 22, 5337
por: Mahmoudi, Ghodrat, et al.
Publicado: (2022)

Design of a multi-epitope vaccine against SARS-CoV-2: immunoinformatic and computational methods
por: Rafi, Md. Oliullah, et al.
Publicado: (2022)

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
por: Jayk Bernal, Angélica, et al.
Publicado: (2021)

Antiviral Efficacy of Molnupiravir for COVID-19 Treatment
por: Bai, Yuan, et al.
Publicado: (2022)

Efficacy and safety of molnupiravir for COVID-19 patients
por: Fatima, Maurish, et al.
Publicado: (2022)

Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19
por: Kauer, Victoria, et al.
Publicado: (2023)

Vascularite rétinienne post-Covid-19 et Molnupiravir
por: Lassouli, I., et al.
Publicado: (2022)

PANORAMIC: important insights into molnupiravir use in COVID-19
por: Kidd, Michael R, et al.
Publicado: (2023)

Molnupiravir: A new candidate for COVID‐19 treatment
por: Pourkarim, Fariba, et al.
Publicado: (2021)

Healthcare worker access to molnupiravir: A case series
por: O’Keeffe, Jessica C., et al.
Publicado: (2023)

Molnupiravir and Its Antiviral Activity Against COVID-19
por: Tian, Lili, et al.
Publicado: (2022)

Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity
por: Yip, Ashley Jia Wen, et al.
Publicado: (2022)

Molnupiravir in COVID-19: A systematic review of literature
por: Singh, Awadhesh Kumar, et al.
Publicado: (2021)

What will be the role of molnupiravir in the treatment of COVID-19 infection?
por: Vitiello, Antonio, et al.
Publicado: (2021)

Electrochemical, spectroscopic, and molecular docking studies of the interaction between the anti-retroviral drug indinavir and dsDNA
por: Mollarasouli, Fariba, et al.
Publicado: (2020)

Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
por: Kabinger, Florian, et al.
Publicado: (2021)

Clinical effectiveness of molnupiravir in patients with COVID-19 undergoing haemodialysis
por: Chang, Yi-Chin, et al.
Publicado: (2023)

Molnupiravir Inhibits Porcine Epidemic Diarrhea Virus Infection In Vitro
por: Huang, Zi-Xin, et al.
Publicado: (2023)

Green adherent spectrophotometric determination of molnupiravir based on computational calculations; application to a recently FDA-approved pharmaceutical dosage form
por: Abdelazim, Ahmed H., et al.
Publicado: (2023)

Molnupiravir and Nirmatrelvir/Ritonavir: Tolerability, Safety, and Adherence in a Retrospective Cohort Study
por: Mazzitelli, Maria, et al.
Publicado: (2023)

Efficacy of Molnupiravir for the Treatment of Mild or Moderate COVID-19 in Adults: A Meta-Analysis
por: Benaicha, Karima, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oefi36or4gpl9hcnfcmj1gv7t5